Adaptation, PhysiologicalAMP-Activated Protein KinasesDNA Methylation
Nurbek Mambetsariev
NPI1467957100
- Part D claims, 2024
- 15
- Publications
- 16
- Industry payments
- $4,002
- State license
- 1
- Year NPI issued
- 2018
- Practice address
- 251 E Huron St, Chicago, IL 60611
- Practice phone
- Call (312) 926-2000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Nurbek Mambetsariev's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Nurbek Mambetsariev is an internist in Chicago, Illinois
Nurbek Mambetsariev practices in Chicago, Illinois.
Nurbek Mambetsariev's NPI, 1467957100, was assigned on March 26, 2018. Nurbek Mambetsariev holds Illinois license 125.071983.
NPI and contact details
- NPI
- 1467957100NPI Registry (opens in a new tab)
- NPI enumeration date
- March 26, 2018
- NPI status
- Active
- Practice phone
- (312) 926-2000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Nurbek Mambetsariev's practice address is in Chicago, Illinois
Nurbek Mambetsariev's practice address in the NPI Registry is 251 E Huron St, Chicago, IL 60611, in Cook County. The practice phone is (312) 926-2000.
- NPI Registry address251 E Huron St, Chicago, IL 60611 · Cook CountyPhone(312) 926-2000
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Nurbek Mambetsariev's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Nurbek Mambetsariev practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Nurbek Mambetsariev's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Nurbek Mambetsariev practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Nurbek Mambetsariev is one of 5,652 internists in Illinois
Internal medicine is Nurbek Mambetsariev's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Nurbek Mambetsariev is licensed in Illinois.
Specialties and state licenses
- Internal medicine, IllinoisPrimary
Internists near Nurbek Mambetsariev
Counts of internists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Nurbek Mambetsariev's patients have a median age of 61
Across all payers, Dmand AI patient panel data puts Nurbek Mambetsariev's median patient age at 61, with 100% women.
Nurbek Mambetsariev's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 61
Patient panel by sex, all payers
- Women100%
- Men0%
Source: Dmand AI Patient Panel Data
Nurbek Mambetsariev wrote 15 Medicare Part D claims in 2024
In 2024, Nurbek Mambetsariev wrote 15 Medicare Part D claims. Every claim was for a generic drug. They cover 2 drugs, with $1,938 in total drug cost. In 2021, CMS named 130 claims across 6 drugs.
Part D claims, 202415
Drugs named by CMS2
Total drug cost$1,938
Nurbek Mambetsariev's most prescribed drugs by claims, 2022
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2021 to 2022
- 2021
- 2022
- Claims for drugs CMS names
- 2021: 1302022: 4069%
Drugs named by CMS: 2 in 2022, 6 in 2021.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Find internists like Nurbek Mambetsariev by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Nurbek Mambetsariev has 16 publications on record
Dmand AI links 16 papers to Nurbek Mambetsariev, published from 2010 to 2025. 2010 was the busiest year, with 2. The most frequent topics are Mice, Inbred C57BL, Mice, Knockout and B-Lymphocytes. Nurbek Mambetsariev has published most often in bioRxiv. Nurbek Mambetsariev's most frequent co-authors are Anthony Merhej Joudi, MD and Jessica Hope Siegler, MD.
Papers16
Years published2010 to 2025
Nurbek Mambetsariev's papers by year, 2010 to 2025
Topics Nurbek Mambetsariev writes about most
- Mice, Inbred C57BL
- Mice, Knockout
- B-Lymphocytes
- Cell Line
- TNF Receptor-Associated Factor 3
- Acute Lung Injury
- Cell Line, Tumor
- Cell Survival
Nurbek Mambetsariev's most frequent co-authors
Recent publications by Nurbek Mambetsariev
J Clin Invest
Acute Lung InjuryForkhead Transcription FactorsInflammation
See who Nurbek Mambetsariev researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Nurbek Mambetsariev works with, so you can find a warm path to the right internists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Nurbek Mambetsariev received $4,002 in industry payments from 2021 to 2023
CMS Open Payments shows 38 general payments to Nurbek Mambetsariev from 7 drug and device companies from 2021 to 2023. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,825.
General payments to Nurbek Mambetsariev by program year, 2021 to 2023
Companies that paid Nurbek Mambetsariev the most, 2021 to 2023
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Nurbek Mambetsariev's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Nurbek Mambetsariev
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Nurbek Mambetsariev's NPI number?
Nurbek Mambetsariev's NPI number is 1467957100. It was assigned on March 26, 2018, and it is active in the NPI Registry.
What does Nurbek Mambetsariev specialize in?
Nurbek Mambetsariev is an internist in Chicago, Illinois. The primary specialty in the NPI Registry is Internal Medicine Physician (taxonomy code 207R00000X).
Where does Nurbek Mambetsariev practice?
Nurbek Mambetsariev practices at 251 E Huron St, Chicago, IL 60611.
What is Nurbek Mambetsariev's office phone number?
The practice phone on file for Nurbek Mambetsariev is (312) 926-2000.
What is Nurbek Mambetsariev's medical license number?
Nurbek Mambetsariev holds Illinois license 125.071983.
What drugs does Nurbek Mambetsariev prescribe most?
In 2022 Medicare Part D data, Nurbek Mambetsariev's most prescribed drugs by claims were Azelastine HCl and Fluticasone Propionate.
Has Nurbek Mambetsariev received payments from drug or device companies?
CMS Open Payments shows $4,002 in general payments to Nurbek Mambetsariev from 7 companies from 2021 to 2023. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Nurbek Mambetsariev been practicing?
Nurbek Mambetsariev's NPI was assigned in 2018.
Does Nurbek Mambetsariev do research?
Dmand AI links 16 publications to Nurbek Mambetsariev, published from 2010 to 2025.
Who does Nurbek Mambetsariev publish with?
Nurbek Mambetsariev's most frequent co-authors are Anthony Merhej Joudi, MD (5 shared papers) and Jessica Hope Siegler, MD (1 shared paper).
Selling to internal medicine practices?
See internists in Illinois by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card